Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Nicotinic Acid | HCID 938 | — |
| Reactant | Diethyl Ether | HCID 3283 | — |
| Reactant | Sodium t-butoxide | HCID 23676156 | — |
| Reactant | 5-(Furan-3-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine | HCID 25215938 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 25181485 | HCID 25181485 | 34.3% |
Reaction Steps
A solution of nicotinic acid (74 mg, 0.6 mmol, 1.2 eq.) and 1,1-carbonyldiimidazole (122 mg, 0.75 mmol, 1.5 eq.) in dry THF (1 mL) was stirred for 45 min. at rt. In parallel, a solution of 5-(3-furyl)[1,2,4]triazolo[1,5-a]pyridin-2-amine ((A2), 100 mg; 0.50 mmol; 1.0 eq.) and sodium tert-butoxide (96 mg, 1.0 mmol, 2.0 eq.) in dry THF (2 mL) was stirred for 45 min. at rt. The two solutions were then combined and the reaction mixture was stirred overnight at rt. Et2O was then added and the precipitate obtained was filtered, washed with Et2O, THF, a 5N solution of NaOH and water. It was resuspended in an acidic aqueous solution (pH 1) and filtered to give the title compound as a white powder (52.4 mg, 31%). HPLC, Rt: 1.98 min. (purity 95.1%). LC/MS, M+(ESI): 306.1, M−(ESI): 304.1.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08263595B2 |
|---|
| Source dataset | uspto-grants-2012_09 |
|---|
| ORD ID | ord-0b33088555854c4596c530834b73e1b2 |
|---|
| Source note | uspto-grants-2012_09 |
|---|